Massive Selection for Bilberry extract in United States
Massive Selection for Bilberry extract in United States Detail:
[Latin Name] Vaccinium myrtillus l.
[Plant Source] Wild bilberry fruit cultivated from Sweden & Finland
[Specifications]
1) Anthocyanidins 25% UV (Glycosyl removed)
2) Anthocyanins 25% HPLC
3) Anthocyanins 36% HPLC
[Particle size] 80 Mesh
[Loss on drying] ≤5.0%
[Heavy Metal] ≤10PPM
[Pesticide residue] EC396-2005, USP 34, EP 8.0, FDA
[Storage] Store in cool & dry area, keep away from the direct light and heat.
[Package] Packed in paper-drums and two plastic-bags inside.
[General feature]
1. 100% extracted from European bilberry fruit, approved ID test from ChromaDex andAlkemist Lab;
2.Without any adultery of other relative species of Berries,such as Blueberry, Mulberry,Cranberry,etc;
3. Pesticide residue: EC396-2005, USP 34, EP 8.0, FDA
4. Directly import the frozen fruit from North Europe;
5. Perfect water solubility,water insolubles<1.0%
6. Chromatographic fingerprint match EP6 requirement
[What is bilberry fruit]
Bilberry (Vaccinium Myrtillus L.) is a kind of perennial deciduous or evergreen fruit shrubs, mainly found in subarctic regions of the world as in Sweden, Finland and Ukraine, etc. Bilberries contain dense levels of anthocyanin pigments, which was said popularly to have been used by World War II RAF pilots to sharpen night vision. In fork medicine, Europeans have been taking bilberry for a hundred years. Bilberry extracts entered the healthcare market as a kind of dietary supplement for effects on vision enhancement and visual fatigue relief.
[Function]
Protect and regenerate rhodopsin and cure the eye diseases;
Prevent the cardiovascular diseases
Antioxidant and anti-aging
Softening blood capillary, enhancing the heart function and resisting cancer
Product detail pictures:

Related Product Guide:
Fast and great quotations, informed advisers to help you choose the correct product that suits all your preferences, a short creation time, responsible top quality control and different services for paying and shipping affairs for Massive Selection for Bilberry extract in United States , The product will supply to all over the world, such as: Jordan, Kazakhstan, Boston, With the intensified strength and more reliable credit, we are here to serve our customers by providing the highest quality and service, and we sincerely appreciate your support. We will endeavor to maintain our great reputation as the best products supplier in the world. If you have any questions or comments, please contact with us freely.
Zunka is a very simple and a traditional Maharashtrian dish. This dish is often confused with another Maharashtrian dish Pithla, but they are not the same.
Preparation time: 20 mins.
Ingredients: 0:52
1 cup Gram Floor (Basen)
2 tbsp Oil
2 Onions, chopped
1 Bunch, Spring Onions (optional, if we don’t have spring onions add 1 more chopped onion)
1 tsp Ginger / Garlic paste
Coriander Leaves
4 Red / Green Chilies, chopped finely
1/4 tsp Mustard Seeds (Rai)
1/4 tsp Turmeric powder
1 tsp Mix Masala (any other masala like a malvani masala,parbhi sambar,etc.) / Red Chilli Powder
Pinch of Asafoetida (Hinga)
Salt to Taste
1/4 tsp Sugar (optional)
Method: 1:55
- Heat some oil in a Pan
- Add Mustard Seeds (Rai)
- Add pinch of Asafoetida (Hinga).
- Add ginger / garlic paste.
- Add the chopped chillies. (if we want to make it more spicy we can add more green chillies)
- Add some coriander
- Add chopped onions and spring onions. Sauté well.
- Add turmeric powder, Mix masala, salt & sugar(optional). Mix well.
- Add the little water.
- Add gram floor / basen
- Sprinkle some water and mix well
- Cover the pan and cook for 4 mins
- After 4 mins, open and check, if the gram floor is cooked then your zunka is ready, else if there is still some raw smell of zunka, sprinkle some more water and cook for another 3 mins.
- Garnish it with coriander leaves and spring onion greens and serve hot!
Subscribe to Indian Varieties for more recipes every Wednesday 5 pm Sydney Time:
https://www.youtube.com/c/IndianVarie…
Indian Varieties on Social Media:
YouTube- https://www.youtube.com/c/IndianVarie…
Facebook- https://www.facebook.com/IndiaVarieties
Twitter- https://twitter.com/IndianVarieties
This is the gear used for creating this video!
———Camera——-
Nikon D3100 Digital SLR Camera
https://amzn.to/2mFgzFQ
———Lens——-
Canon EF-S 10-18mm
https://amzn.to/2n8lFqj
———-Microphone——-
BOYA BY-M1 Lavalier Clip Microphone
https://amzn.to/2nlz2nQ
DISCLAIMER: This video and description contains affiliate links, which means that if you click on one of the product links, I’ll receive a small commission. Thank you for the support!
CX3CR1 Is Expressed in Differentiated Human Ciliated Airway Cells and Co-Localizes with Respiratory Syncytial Virus on Cilia in a G Protein-Dependent Manner. Kwang-Il Jeong et al (2015), PLoS ONE https://dx.doi.org/10.1371/journal.pone.0130517
Respiratory syncytial virus (RSV) is the principal cause of bronchiolitis in infants and a significant healthcare problem. The RSV Glycoprotein (G) mediates attachment of the virus to the cell membrane, which facilitates interaction of the RSV Fusion (F) protein with nucleolin, thereby triggering fusion of the viral and cellular membranes. However, a host protein ligand for G has not yet been identified. Here we show that CX3CR1 is expressed in the motile cilia of differentiated human airway epithelial (HAE) cells, and that CX3CR1 co-localizes with RSV particles. Upon infection, the distribution of CX3CR1 in these cells is significantly altered. Complete or partial deletion of RSV G results in viruses binding at least 72-fold less efficiently to cells, and reduces virus replication. Moreover, an antibody targeting an epitope near the G protein’s CX3CR1-binding motif significantly inhibits binding of the virus to airway cells. Given previously published evidence of the interaction of G with CX3CR1 in human lymphocytes, these findings suggest a role for G in the interaction of RSV with ciliated lung cells. This interpretation is consistent with past studies showing a protective benefit in immunizing against G in animal models of RSV infection, and would support targeting the CX3CR1-G protein interaction for prophylaxis or therapy. CX3CR1 expression in lung epithelial cells may also have implications for other respiratory diseases such as asthma.

The enterprise has a strong capital and competitive power, product is sufficient, reliable, so we have no worries on cooperating with them.
